These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Nawarskas J; Rajan V; Frishman WH Heart Dis; 2001; 3(6):378-85. PubMed ID: 11975822 [TBL] [Abstract][Full Text] [Related]
12. Effects of omapatrilat on pharmacodynamic biomarkers of neutral endopeptidase and Angiotensin-converting enzyme activity in humans. Vesterqvist O; Reeves RA Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S22-7. PubMed ID: 11716802 [TBL] [Abstract][Full Text] [Related]
13. The natriuretic peptide neurohormonal system modulation by vasopeptidase inhibitors--the novel therapeutical approach of hypertension treatment. Machowska A; Juszczak K; Novak P; Thor P Folia Med Cracov; 2009; 50(3-4):35-42. PubMed ID: 21853869 [TBL] [Abstract][Full Text] [Related]
14. Dual ACE and neutral endopeptidase inhibitors: novel therapy for patients with cardiovascular disorders. Tabrizchi R Drugs; 2003; 63(20):2185-202. PubMed ID: 14498755 [TBL] [Abstract][Full Text] [Related]
15. Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system. Regoli D; Gobeil F Can J Physiol Pharmacol; 2017 Oct; 95(10):1117-1124. PubMed ID: 28384411 [TBL] [Abstract][Full Text] [Related]
16. Current role of neprilysin inhibitors in hypertension and heart failure. von Lueder TG; Atar D; Krum H Pharmacol Ther; 2014 Oct; 144(1):41-9. PubMed ID: 24836726 [TBL] [Abstract][Full Text] [Related]
17. Vasopeptidase inhibition and endothelial function in hypertension. d'Uscio LV; Lüscher TF Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S6-14. PubMed ID: 11716800 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension. Maniu CV; Meyer DM; Redfield MM Hypertension; 2002 Oct; 40(4):528-34. PubMed ID: 12364358 [TBL] [Abstract][Full Text] [Related]
19. Vasopeptidase inhibition: a new direction in cardiovascular treatment. Asher JR; Naftilan AJ Curr Hypertens Rep; 2000 Aug; 2(4):384-91. PubMed ID: 10981174 [TBL] [Abstract][Full Text] [Related]
20. Evidence for cardioprotective, renoprotective, and vasculoprotective effects of vasopeptidase inhibitors in disease. Kubota E; Dean RG; Hubner RA; Balding LC; Johnston CI; Burrell LM Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S31-3. PubMed ID: 11716804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]